Rayner, the UK’s sole manufacturer of intraocular lenses (IOLs) and a global leader in cataract surgery solutions, has received the prestigious King’s Award for Enterprise 2025 in the Innovation category for its groundbreaking RayOne EMV lens.
Launched in 2020 and developed with Professor Graham Barrett, RayOne EMV features a patented non-diffractive optic that extends patients' range of vision using controlled positive spherical aberration. This lens offers:
- Up to 1.5 D increased range of focus with an emmetropic target1,4,6
- Monofocal levels of contrast sensitivity and low dysphotopsia1,2,3,5
- High patient satisfaction and smooth visual transitions in Enhanced Monovision setups2,4
Over 400,000 RayOne EMV lenses have been shipped to more than 65 countries, including the USA. With recent approval by China’s NMPA and the upcoming U.S. launch of RayOne EMV Toric, global adoption continues to grow.
On the award, Professor Graham Barrett said “RayOne EMV was the culmination of years of work so I am truly honoured to see this innovation recognised with The King’s Award for Enterprise. I look forward to many more patients benefiting from RayOne EMV’s unique optical technology over the coming years.”
“Surgeons and patients place immense trust in us to deliver life-enhancing visual outcomes — and this award is a powerful recognition of that,” echoed Tim Clover, Rayner CEO. “It reflects the real-world impact of our technology, the trust placed in RayOne EMV, and the commitment of our teams.”
The King’s Awards, formerly The Queen’s Awards, are the UK’s highest business honour. Now in their 59th year, the 2025 awards recognised 197 outstanding organisations across the country.
Not all Rayner products are approved for sale in every country. Please contact your local Rayner distributor for details of which products are available in your area.
References:
1.Ferreira TB. Comparison of visual outcomes of a monofocal, two enhanced monofocals and two extended depth of focus intraocular lenses. Presented at ESCRS 2022.
2. RayOne EMV: First Clinical Results, Rayner. Oct 2020.
3. Rayner RayPRO, data on file.
4. Rayner, data on file.
5. Rayner Peer2Peer webinar. May 2022.
6. Royo, M. RayOne EMV and TECNIS Eyhance: A Comparative Clinical Defocus Curve. Data on file. 2021.
